Comprehensive Clinical Guide: Type I Pelvic Resection (Ilium)

1. Introduction and Clinical Overview

Type I pelvic resection, specifically involving the ilium, represents one of the most technically demanding procedures in orthopedic oncology. As defined by the Enneking and Dunham classification system, a Type I resection involves the removal of the ilium. This procedure is typically indicated for primary malignant bone tumors (such as osteosarcoma, chondrosarcoma, or Ewing sarcoma) or aggressive benign lesions that threaten the structural integrity of the pelvic ring.

Because the ilium serves as the primary attachment point for several critical muscle groups—including the gluteal musculature and the abdominal wall—resection presents unique challenges regarding post-operative stability, gait mechanics, and visceral support. This guide serves as a clinical reference for orthopedic surgeons, surgical oncologists, and rehabilitative specialists involved in the complex care of patients undergoing this procedure.

2. Deep-Dive: Technical Specifications and Mechanisms

The anatomy of the ilium is complex, characterized by its wide surface area and integration into the sacroiliac joint. A Type I resection may be classified as either "extra-articular" (preserving the acetabulum) or "intra-articular" (involving the acetabulum, which would transition the procedure into a Type I+II resection).

Anatomical Landmarks for Resection

• Superior boundary: Iliac crest.
• Inferior boundary: Supra-acetabular region.
• Medial boundary: Sacroiliac joint or sacral ala.
• Lateral boundary: Gluteal surface.

Surgical Mechanics

The primary goal is the achievement of wide surgical margins (R0 resection). The surgeon must navigate the "danger zones" of the pelvis, specifically the neurovascular bundles, including the femoral nerve, the external iliac vessels, and the sciatic nerve.

3. Extensive Clinical Indications and Usage

The decision to perform a Type I resection is rarely unilateral; it is the culmination of a multidisciplinary tumor board review.

Primary Indications

• Malignant Bone Tumors: High-grade chondrosarcoma, osteosarcoma, and localized Ewing sarcoma unresponsive to neoadjuvant chemotherapy.
• Metastatic Disease: Solitary metastatic lesions from renal cell or thyroid carcinoma where local control is achievable.
• Aggressive Benign Lesions: Giant cell tumors (GCT) or aggressive desmoid tumors that have caused extensive cortical destruction.

Patient Selection Criteria

1. Tissue Planes: Clear separation between the tumor and the neurovascular structures.
2. Functional Status: Pre-operative ambulatory status and systemic health (ECOG performance status).
3. Imaging: MRI/CT fusion to define the extent of extra-osseous soft tissue involvement.

4. Pre-Operative Preparation

Pre-operative planning is the most critical phase of the procedure.

• Vascular Mapping: CT Angiography to identify variant pelvic vasculature.
• Neoadjuvant Therapy: Administration of chemotherapy or radiation (if applicable) to shrink tumor volume and define the pseudocapsule.
• Custom Implant Design: If the resection is massive, 3D-printed custom pelvic endoprostheses are often manufactured using patient-specific CT data to ensure anatomical fit.
• Embolization: In hypervascular tumors (e.g., renal cell metastasis), pre-operative arterial embolization is mandatory to reduce intraoperative blood loss.

5. The Procedure: Step-by-Step Surgical Intervention

1. Patient Positioning: Typically lateral decubitus or modified semi-lateral, allowing for access to both the iliac crest and the posterior sacral region.
2. Incision: A modified ilioinguinal or "bikini" incision, often extended posteriorly towards the sacroiliac joint.
3. Dissection: Careful mobilization of the abdominal musculature from the iliac crest.
4. Neurovascular Protection: Identification and mobilization of the femoral nerve and external iliac vessels. The psoas muscle is retracted medially.
5. Osteotomy: Using an oscillating saw or Gigli saw, the osteotomies are performed. The first cut is usually through the supra-acetabular region, followed by the sacroiliac junction.
6. Reconstruction:
   • Biological: Iliac crest bone graft or massive allograft (rare due to non-union risks).
   • Endoprosthetic: Custom 3D-printed titanium mesh or pelvic cage to restore pelvic ring continuity and provide an anchor for gluteal muscles.
7. Closure: Multi-layered closure, often requiring a rotational flap (e.g., rectus abdominis or tensor fascia lata) to cover the defect and prevent wound dehiscence.

6. Post-Operative Recovery Protocol

Recovery follows a structured orthopedic oncology rehabilitation pathway.

• Phase I (Weeks 0–6): Protected weight-bearing. Patients are typically restricted to toe-touch weight-bearing (TTWB) to allow for soft tissue healing and initial osseointegration of the implant.
• Phase II (Weeks 6–12): Transition to partial weight-bearing (PWB) under the guidance of physical therapy. Focus on isometric core stabilization.
• Phase III (Months 3+): Progressive resistance training. Strengthening of the hip abductors is paramount to address the Trendelenburg gait often associated with iliac resection.

7. Risks, Side Effects, and Complications

Pelvic resections are associated with high morbidity rates.

• Infection: One of the most significant risks, often exacerbated by large dead space and prior radiation.
• Neurovascular Injury: Transient or permanent foot drop (sciatic nerve) or sensory deficits in the distribution of the femoral nerve.
• Implant Failure: Mechanical loosening of the pelvic hardware, particularly at the sacral interface.
• Non-Union: Failure of bone graft incorporation if biological reconstruction is attempted.
• Wound Complications: Necrosis of skin flaps due to tension, requiring secondary plastic surgical intervention.

8. Alternative Treatments

• Limb Salvage with Radiation: For tumors that are radiosensitive (e.g., Ewing sarcoma), definitive radiation therapy may be considered if surgery is deemed too mutilating.
• Internal Hemipelvectomy: An aggressive variation where the entire hemipelvis is removed, often requiring specialized orthotic bracing for life.
• Palliative Care: In metastatic cases with poor prognosis, focus shifts to pain management and stabilization (e.g., cementoplasty) rather than wide resection.

9. FAQ Section (Frequently Asked Questions)

Q1: How long is the expected hospital stay for a Type I resection?
A: Typically 7 to 14 days, depending on the complexity of the reconstruction and the patient’s ability to mobilize with physical therapy.

Q2: Will I walk normally after this surgery?
A: Most patients return to a functional gait, though a slight limp (Trendelenburg gait) may persist if the gluteus medius attachment is compromised.

Q3: Can 3D-printed implants be used in all cases?
A: They are increasingly the gold standard for reconstruction, as they allow for patient-specific geometry and improved osseointegration via trabecular surfaces.

Q4: What is the risk of local recurrence?
A: Local recurrence depends on the tumor grade and the achievement of wide margins. It ranges from 10% to 25% for high-grade malignancies.

Q5: Is physical therapy mandatory?
A: Yes. Specialized oncology rehabilitation is critical to regain core strength and compensate for the biomechanical changes in the pelvis.

Q6: What are the early signs of infection?
A: Persistent drainage from the wound, increasing localized redness, fever, or sudden onset of deep, throbbing pain.

Q7: How is the sciatic nerve protected during the procedure?
A: The surgeon meticulously dissects the nerve from the tumor pseudocapsule, often utilizing intraoperative nerve monitoring to ensure functionality.

Q8: Can I undergo chemotherapy after the surgery?
A: Yes, adjuvant chemotherapy is typically initiated 4–6 weeks post-operatively, provided the surgical wound is fully healed.

Q9: What is the difference between a Type I and Type II resection?
A: A Type I involves the ilium only; a Type II involves the periacetabular region, which necessitates a more complex reconstruction to support the hip joint.

Q10: Are there long-term limitations on physical activity?
A: High-impact activities (running, jumping) are generally discouraged to preserve the longevity of the pelvic hardware.

10. Clinical Summary Table: Managing Complications

11. Conclusion

Type I pelvic resection of the ilium remains a cornerstone of oncological orthopedics. Success is predicated on meticulous pre-operative imaging, precise surgical execution, and a dedicated, long-term post-operative rehabilitation plan. While the procedure carries inherent risks, modern advancements in 3D-printed endoprostheses and multidisciplinary care have significantly improved the functional outcomes and quality of life for patients facing these complex pelvic pathologies. Surgeons must weigh the radical nature of the resection against the necessity of oncological control, ensuring that every intervention is tailored to the individual patient's anatomical and prognostic profile.